Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | GHSR | Q92847 | 2/20 | 0.57 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.56 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.56 |
| ▸ | ITGAL | P20701 | 1/20 | 0.56 |
| ▸ | ACE | P12821 | 2/20 | 0.53 |
| ▸ | ECE1 | P42892 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30052130 | 0.97 | GHSR (0.59) | MEN1KMT2AGHSRITGB2ICAM1 | |
| SCHEMBL29533411 | 0.90 | GHSR (0.65) | GHSRITGB2ICAM1ITGALACE | |
| SCHEMBL29533628 | 0.89 | ITGB2 (0.67) | GHSRITGB2ICAM1ITGALACE | |
| SCHEMBL29904257 | 0.89 | ITGB2 (0.67) | GHSRITGB2ICAM1ITGALACE | |
| SCHEMBL21641801 | 0.89 | ITGB2 (0.67) | GHSRITGB2ICAM1ITGALACE | |
| SCHEMBL29144196 | 0.89 | ITGB2 (0.67) | GHSRITGB2ICAM1ITGALACE | |
| SCHEMBL21641802 | 0.89 | ITGB2 (0.67) | GHSRITGB2ICAM1ITGALACE | |
| SCHEMBL2181464 | 0.87 | ECE1 (0.62) | GHSRITGB2ICAM1ITGALACE | |
| SCHEMBL9653545 | 0.87 | ECE1 (0.62) | GHSRITGB2ICAM1ITGALACE | |
| SCHEMBL31609182 | 0.87 | GHSR (0.63) | GHSRITGB2ICAM1ITGALACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119775353-A | Short peptide compound and preparation method thereof, cosmetic composition and application | 常州市智态生创科技有限公司 | 2025-04-08 | — | — | CN | claimed |
| US-12622975-B2 | Peptide-conjugated prodrugs | BRANDEIS UNIVERSITY (US) | 2026-05-12 | — | — | US | disclosed |
| CN-119775353-A | Short peptide compound and preparation method thereof, cosmetic composition and application | 常州市智态生创科技有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-116789747-A | Hypolipidemic oligopeptide from laver protein and application thereof | 浙江海洋大学 | 2023-09-22 | — | — | CN | disclosed |
| US-20220387610-A1 | PEPTIDE-CONJUGATED PRODRUGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622975-B2 | Peptide-conjugated prodrugs | PEPD, PAM, VIP | MEN1 1217/4885KMT2A 1801/4885GHSR 429/4885 |
| US-20220387610-A1 | PEPTIDE-CONJUGATED PRODRUGS | VIP, DNPEP, PEPD | MEN1 1147/4885KMT2A 4547/4885GHSR 679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.